Evidence map›Paper›PMID 24358031›Full record

ArticlePLoS medicine2013

Major burden of severe anemia from non-falciparum malaria species in Southern Papua: a hospital-based surveillance study.

Nicholas M Douglas, Daniel A Lampah, Enny Kenangalem, Julie A Simpson, Jeanne R Poespoprodjo, Paulus Sugiarto, Nicholas M Anstey, Ric N Price

Open access · goldAbstract read
In one paragraph

Article in PLoS medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 105 papers, 14 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed, 14 pooled it
11.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

105 citing papers in PubMed, 14 syntheses or guidelines pooled it, 151 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. The Vivax Surveyor: Online mapping database for Plasmodium vivax clinical trials.International journal for parasitology. Drugs and drug resistance · 2017
    Pooled it
  13. Pooled it
  14. Pooled it
  15. Trial
  16. Provider and household costs ofBulletin of the World Health Organization · 2019
    Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Nicholas M DouglasGlobal Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Australia ; Centre for Tropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford, United Kingdom.
Daniel A LampahTimika Malaria Research Programme, Papuan Health and Community Development Foundation, Timika, Papua, Indonesia.
Enny KenangalemTimika Malaria Research Programme, Papuan Health and Community Development Foundation, Timika, Papua, Indonesia ; Mimika District Health Authority, Timika, Papua, Indonesia.
Julie A SimpsonCentre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, University of Melbourne, Victoria, Australia.
Jeanne R PoespoprodjoGlobal Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Australia ; Timika Malaria Research Programme, Papuan Health and Community Development Foundation, Timika, Papua, Indonesia ; Mimika District Health Authority, Timika, Papua, Indonesia.
Paulus SugiartoRumah Sakit Mitra Masyarakat, Timika, Papua, Indonesia.
Nicholas M AnsteyGlobal Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Australia ; Division of Medicine, Royal Darwin Hospital, Darwin, Australia.
Ric N PriceGlobal Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Australia ; Centre for Tropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford, United Kingdom.
Nuffield Orthopaedic Centre · GBState University of Papua · IDCharles Darwin University · AURoyal Darwin Hospital · AUUniversity of Melbourne · AU

Funding

Wellcome TrustWellcome Trust 091625
6 · The paper itself

Abstract

backgroundThe burden of anemia attributable to non-falciparum malarias in regions with Plasmodium co-endemicity is poorly documented. We compared the hematological profile of patients with and without malaria in southern Papua, Indonesia. METHODS AND

findingsClinical and laboratory data were linked for all patients presenting to a referral hospital between April 2004 and December 2012. Data were available on patient demographics, malaria diagnosis, hemoglobin concentration, and clinical outcome, but other potential causes of anemia could not be identified reliably. Of 922,120 patient episodes (837,989 as outpatients and 84,131 as inpatients), a total of 219,845 (23.8%) were associated with a hemoglobin measurement, of whom 67,696 (30.8%) had malaria. Patients with P. malariae infection had the lowest hemoglobin concentration (n = 1,608, mean = 8.93 [95% CI 8.81-9.06]), followed by those with mixed species infections (n = 8,645, mean = 9.22 [95% CI 9.16-9.28]), P. falciparum (n = 37,554, mean = 9.47 [95% CI 9.44-9.50]), and P. vivax (n = 19,858, mean = 9.53 [95% CI 9.49-9.57]); p-value for all comparisons <0.001. Severe anemia (hemoglobin <5 g/dl) was present in 8,151 (3.7%) patients. Compared to patients without malaria, those with mixed Plasmodium infection were at greatest risk of severe anemia (adjusted odds ratio [AOR] 3.25 [95% CI 2.99-3.54]); AORs for severe anaemia associated with P. falciparum, P. vivax, and P. malariae were 2.11 (95% CI 2.00-2.23), 1.87 (95% CI 1.74-2.01), and 2.18 (95% CI 1.76-2.67), respectively, p<0.001. Overall, 12.2% (95% CI 11.2%-13.3%) of severe anemia was attributable to non-falciparum infections compared with 15.1% (95% CI 13.9%-16.3%) for P. falciparum monoinfections. Patients with severe anemia had an increased risk of death (AOR = 5.80 [95% CI 5.17-6.50]; p<0.001). Not all patients had a hemoglobin measurement, thus limitations of the study include the potential for selection bias, and possible residual confounding in multivariable analyses.

conclusionsIn Papua P. vivax is the dominant cause of severe anemia in early infancy, mixed P. vivax/P. falciparum infections are associated with a greater hematological impairment than either species alone, and in adulthood P. malariae, although rare, is associated with the lowest hemoglobin concentration. These findings highlight the public health importance of integrated genus-wide malaria control strategies in areas of Plasmodium co-endemicity.

Indexed as

AdolescentAdultAgedAnemiaChildChild, PreschoolFemaleHemoglobinsHumansIndonesiaInfantInfant, NewbornMalariaMaleMiddle AgedPlasmodium falciparumHemoglobins

Identifiers

PMID24358031
PMCPMC3866090
OpenAlexW2169059629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.